A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database

A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database

Abstract Lorazepam is extensively used to treat anxiety disorders and anxiety associated with depression. This study evaluates the safety of lorazepam based on real-world data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Data were collected from January 2004 to...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunyue Fang, Xiaoyan Xu, Jianyi Li, Yuanyuan Zhong, Wei Dai, Jin Wen, Qionghui Yang, Ruixiang Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Anxiety
Lorazepam
Pharmacovigilance
FAERS
Adverse events
Online Access:https://doi.org/10.1038/s41598-025-05680-z
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.1038/s41598-025-05680-z

Similar Items